miR-146a rs291064 Identified as Risk Factor for Gastric Cancer
the Cancer Therapy Advisor take:
Investigators found an association between miR-146a rs291064 and risk of gastric cancer (GC) development, according to an article published online in the journal European Journal of Cancer Care.
The authors performed a meta-analysis using PubMed and China National Knowledge Infrastructure searches in order to find relevant studies published before July 2014.
In total, seven case-control studies were chosen for the data analysis, including 3,283 cases and 4,535 controls.
Results showed a significant correlation between the genetic polymorphism miR-146a rs291064 and risk of GC under all genetic models (CC vs. GG, OR=0.76, 95% CI: 0.66, 0.87; CC vs. GC+GG, OR=0.84, 95% CI: 0.71, 0.99; CC+GC vs. GG, OR=0.82, 95% CI: 0.73, 0.91).
Furthermore, the authors conducted subgroup analysis by ethnicity and identified an association in Asian that was determined to be statistically significant.
Investigators found an association between miR-146a rs291064 and risk of gastric cancer development.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Complete Resection of Metastatic Soft Tissue Sarcoma Associated With Improved Disease-specific Survival
- The Challenges of Immunotherapy Re-challenge in Metastatic Melanoma
- FDA Approves Fulvestrant/Abemaciclib Combination for Breast Cancer
- Beta-blockers May Prevent Stress-induced Lung Cancer Treatment Resistance
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- FDA Expands Sunitinib Indication To Include Adjuvant Therapy for Renal Cell Carcinoma
- Ultrasonography May Detect Thyroid Cancer Growth Arrest, Negating Need for Treatment
- Does Education Level Predict PSA Screening and Prostate Cancer Survival?
- Unrelated HSCT, UCBT May Yield Similar Survival Outcomes in Acute Leukemia
- Minimal Residual Disease and Patient Genotype May Inform Relapse Risk Algorithms in ALL